Clinical factors predictive of bone marrow involvement in Hodgkin's disease

被引:13
作者
Spector, N
Nucci, M
DeMorais, JCO
Maiolino, A
Portugal, RD
Costa, MA
Pulcheri, W
机构
[1] UNIV FED RIO DE JANEIRO,UNIV HOSP,SERV HEMATOL,RIO JANEIRO,BRAZIL
[2] UNIV FED RIO DE JANEIRO,UNIV HOSP,PATHOL SERV,RIO JANEIRO,BRAZIL
[3] NATL CANC INST,ONCOL SERV,RIO JANEIRO,BRAZIL
关键词
Hodgkin's disease; bone marrow pathology; bone marrow examination; staging;
D O I
10.3109/10428199709109172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of bone marrow biopsy in the staging of Hodgkin's disease is undergoing reevaluation. We have studied the relationship of clinical factors to the presence of bone marrow involvement in 130 previously untreated patients with Hodgkin's disease. The presence of fever, spleen enlargement, anemia, leukopenia, poor performance status and poor histologic subgroups were positively correlated with the presence of bone marrow involvement in the univariate analysis. In the multivariate analysis, only fever, spleen involvement, leukopenia and poor histologic subgroups were significant. The predictive value of the absence of fever in regard to the absence of bone marrow involvement was 98%. The likelihood of bone marrow involvement in the absence of all four significant factors was only 0.05%. Patients without these clinical factors should probably not be submitted to a bone marrow biopsy as part of the staging procedures performed in Hodgkin's disease.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [41] Hodgkin's disease: From basic science to clinical application
    Tesch, H
    Diehl, V
    LEUKEMIA, 1996, 10 : S74 - S77
  • [42] Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Vinnicombe, Sarah J.
    Reznek, Rodney H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S42 - S55
  • [43] Lymphocyte predominant Hodgkin's disease: Pathology and clinical implication
    Franklin, J
    Tesch, H
    Hansmann, ML
    Diehl, V
    ANNALS OF ONCOLOGY, 1998, 9 : 39 - 44
  • [44] Development of immunotoxins for potential clinical use in Hodgkin's disease
    Barth, S
    Schnell, R
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 1996, 7 : 135 - 141
  • [45] A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease
    Imrie, KR
    Sheridan, B
    Colwill, R
    Crump, M
    Stewart, AK
    McCrae, J
    Danish, R
    Sutton, D
    Romeyer, F
    Keating, A
    LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 555 - 563
  • [46] Bone marrow involvement in lymphoma: The importance of marrow magnetic resonance imaging
    Takagi, S
    Tsunoda, S
    Tanaka, O
    LEUKEMIA & LYMPHOMA, 1998, 29 (5-6) : 515 - 522
  • [47] Hemophagocytic syndrome as the primary clinical symptom of Hodgkin's disease
    Kojima, H
    Takei, N
    Mukai, HY
    Hasegawa, Y
    Suzukawa, K
    Nagata, M
    Noguchi, M
    Mori, N
    Nagasawa, T
    ANNALS OF HEMATOLOGY, 2003, 82 (01) : 53 - 56
  • [48] Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Sarah J. Vinnicombe
    Rodney H. Reznek
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S42 - S55
  • [49] Hodgkin's disease
    Ekstrand, BC
    Horning, SJ
    BLOOD REVIEWS, 2002, 16 (02) : 111 - 117
  • [50] Hodgkin's disease
    Diehl, V
    Josting, A
    CANCER JOURNAL, 2000, 6 : S150 - S158